{
  "id": 4551448,
  "title": "China shows way in new pharma race: Own meds, don’t just make ’em",
  "url": "https://urgent.news/2026/08/31/china-shows-way-in-new-pharma-race-own-meds-dont-just-make-em",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-31T01:51:35.000Z",
  "source": {
    "name": "Asia Times",
    "slug": "asia-times",
    "url": "https://asiatimes.com/2026/08/chinas-ahead-in-new-pharma-race-own-meds-dont-just-make-them/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Pharmaceutical geopolitics is usually mapped through factories. China’s vast pharmaceutical supply chain, India’s strength in low-cost generics and the concentration of patented drug discovery in richer economies have shaped that discussion for years. But that map is becoming incomplete. Two developments in China this past week point to the next layer of competition. Jiangsu province […] The post…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}